Logo image of NXGN

NEXTGEN HEALTHCARE INC (NXGN) Stock Analyst Earnings Estimates

NASDAQ:NXGN - Nasdaq - US65343C1027 - Common Stock - Currency: USD

23.94  +0.03 (+0.13%)

After market: 23.93 -0.01 (-0.04%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
NXGN revenue by date.NXGN revenue by date.
556.8M
3.07%
596.35M
7.10%
653.172M
9.53%
732.42M
12.13%
785.66M
7.27%
839.25M
6.82%
895.87M
6.75%
957.17M
6.84%
1.024B
6.98%
1.095B
6.93%
EBITDA
YoY % growth
NXGN ebitda by date.NXGN ebitda by date.
70.1M
3.09%
53.418M
-23.80%
38.464M
-27.99%
125.38M
225.97%
147.02M
17.26%
175.51M
19.38%
198.9M
13.33%
220.83M
11.03%
244.8M
10.85%
270.71M
10.58%
EBIT
YoY % growth
NXGN ebit by date.NXGN ebit by date.
20.9M
3.47%
11.103M
-46.88%
1.77M
-84.06%
100.11M
5,555.93%
120.59M
20.46%
142.55M
18.21%
164.02M
15.06%
183.5M
11.88%
204.82M
11.62%
228.07M
11.35%
Operating Margin
NXGN operating margin by date.NXGN operating margin by date.
3.75%1.86%0.27%13.67%15.35%16.99%18.31%19.17%20.00%20.83%
EPS
YoY % growth
NXGN eps by date.NXGN eps by date.
0.98
18.07%
0.97
-1.02%
0.98
1.03%
1.12
14.49%
1.36
21.27%
1.58
16.19%
1.94
22.58%
2.16
11.58%
2.42
11.79%
2.69
11.39%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.28
7.23%
0.30
-4.58%
0.30
26.08%
0.32
2.00%
0.35
27.14%
0.38
28.45%
0.37
21.35%
0.34
6.45%
0.40
12.23%
0.43
12.75%
Revenue
Q2Q % growth
182.03M
12.45%
189.39M
6.07%
194.84M
9.33%
192.95M
9.37%
194.16M
6.66%
203.25M
7.32%
206.54M
6.00%
207.15M
7.36%
204.65M
5.40%
216.39M
6.46%
EBITDA
Q2Q % growth
32.575M
-11.11%
35.113M
112.50%
35.454M
88.45%
36.783M
36.99%
37.066M
13.79%
40.454M
15.21%
41.045M
15.77%
40.952M
11.33%
43.782M
18.12%
46.331M
14.53%
EBIT
Q2Q % growth
25.081M
155.64%
27.452M
236.10%
27.751M
191.66%
29.049M
252.66%
30.606M
22.03%
33.93M
23.60%
32.89M
18.52%
32.774M
12.82%
35.6M
16.32%
37.68M
11.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
0.31
24.00%
0.250.0623.21%
Q1 2024
Q2Q % growth
0.24
50.00%
0.220.026.95%
Q4 2023
Q2Q % growth
0.31
63.16%
0.290.026.17%
Q3 2023
Q2Q % growth
0.26
8.33%
0.28-0.02-6.17%
Q2 2023
Q2Q % growth
0.25
-13.79%
0.230.027.34%
Q1 2023
Q2Q % growth
0.16
-36.00%
0.160.000.55%
Q4 2022
Q2Q % growth
0.19
-9.52%
0.20-0.01-4.15%
Q3 2022
Q2Q % growth
0.24
-7.69%
0.210.0312.94%
Q2 2022
Q2Q % growth
0.29
-3.33%
0.230.0623.61%
Q1 2022
Q2Q % growth
0.25
19.05%
0.210.0417.96%
Q4 2021
Q2Q % growth
0.21
5.00%
0.200.016.67%
Q3 2021
Q2Q % growth
0.26
13.04%
0.250.013.34%
Q2 2021
Q2Q % growth
0.30
25.00%
0.210.0945.55%
Q1 2021
Q2Q % growth
0.21
31.25%
0.080.13147.07%
Q4 2020
Q2Q % growth
0.20
-13.04%
0.200.000.98%
Q3 2020
Q2Q % growth
0.23
15.00%
0.200.0312.91%
Q2 2020
Q2Q % growth
0.24 0.230.012.43%
Q1 2020
Q2Q % growth
0.16
-15.79%
0.21-0.05-24.14%
Q4 2019
Q2Q % growth
0.23 0.180.0529.92%
Q3 2019
Q2Q % growth
0.20 0.150.0531.99%
Q2 2019
Q2Q % growth
0.24 0.200.0422.29%
Q1 2019
Q2Q % growth
0.19 0.180.014.22%
NXGN Yearly EPS VS EstimatesNXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
176.418M
10.65%
180.49M-4.072M-2.26%
Q1 2024
Q2Q % growth
178.207M
16.25%
176.94M1.267M0.72%
Q4 2023
Q2Q % growth
178.55M
18.04%
174.63M3.92M2.24%
Q3 2023
Q2Q % growth
161.877M
8.12%
165.24M-3.363M-2.04%
Q2 2023
Q2Q % growth
159.443M
6.80%
158.81M633K0.40%
Q1 2023
Q2Q % growth
153.302M
4.94%
155.96M-2.658M-1.70%
Q4 2022
Q2Q % growth
151.259M
4.90%
153.07M-1.811M-1.18%
Q3 2022
Q2Q % growth
149.721M
5.59%
149.25M471K0.32%
Q2 2022
Q2Q % growth
149.286M
6.63%
146.25M3.036M2.08%
Q1 2022
Q2Q % growth
146.084M
11.60%
142.54M3.544M2.49%
Q4 2021
Q2Q % growth
144.2M
5.72%
142.9M1.3M0.91%
Q3 2021
Q2Q % growth
141.8M
2.98%
143.7M-1.9M-1.32%
Q2 2021
Q2Q % growth
140M
4.24%
135.71M4.29M3.16%
Q1 2021
Q2Q % growth
130.9M
-0.76%
116.67M14.23M12.20%
Q4 2020
Q2Q % growth
136.4M
1.19%
138.6M-2.2M-1.59%
Q3 2020
Q2Q % growth
137.7M
5.19%
138.08M-380K-0.28%
Q2 2020
Q2Q % growth
134.3M
3.07%
136.93M-2.63M-1.92%
Q1 2020
Q2Q % growth
131.9M
-0.98%
139.06M-7.16M-5.15%
Q4 2019
Q2Q % growth
134.8M 136.25M-1.45M-1.06%
Q3 2019
Q2Q % growth
130.9M 133.77M-2.87M-2.15%
Q2 2019
Q2Q % growth
130.3M 137.23M-6.93M-5.05%
Q1 2019
Q2Q % growth
133.2M 135.29M-2.09M-1.54%
NXGN Yearly Revenue VS EstimatesNXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.38% -0.97% 0% 0.55%
Revenue0.33% -0.1% 0% -0.06%